Xiaotian Cui

Title: **Inventor Xiaotian Cui: A Pioneer in Tumor-Targeting Therapies**

Introduction

Xiaotian Cui is an innovative inventor based in Shanghai, China, known for his significant contributions to the field of biotechnology. His work focuses on developing therapeutic solutions for cancer treatment, particularly through the creation of novel recombinant proteins.

Latest Patents

Xiaotian Cui holds a patent for a bispecific recombinant protein, which comprises a high affinity tumor-targeting arm and a low affinity fusion protein that blocks the interaction of CD47 with SIRPα. The unique design of this protein allows the high affinity tumor-targeting arm to bind to a target antigen on tumor cells with a binding affinity at least six times greater than that of the corresponding low affinity fusion protein. This innovative approach enhances the potential for developing effective treatments for tumors while minimizing side effects by specifically targeting cancer cells. Moreover, the patent includes nucleic acid molecules encoding these recombinant proteins along with their therapeutic uses for manufacturing medicaments aimed at treating tumors.

Career Highlights

Xiaotian Cui is currently associated with Shanghai Jmt-bio Technology Co., Ltd., where he leverages his expertise to advance cancer research. His work has positioned him as a notable figure in the biotechnology sector, especially in the domain of cancer therapeutics.

Collaborations

Throughout his career, Xiaotian Cui has collaborated with several professionals in his field, including Liping Song and Jian Wang. These collaborations have played a vital role in further developing his pioneering research and enhancing the application of his innovations in clinical settings.

Conclusion

Xiaotian Cui stands out as a remarkable inventor whose patent for a bispecific recombinant protein represents a significant advancement in cancer treatment options. His ongoing work at Shanghai Jmt-bio Technology Co., Ltd. continues to inspire innovations that hold promise for better therapeutic strategies against tumors. With a commitment to pushing the boundaries of biotechnology, Xiaotian Cui is undoubtedly a key player in the fight against cancer.